Document Detail


Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons.
MedLine Citation:
PMID:  15005753     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Here we evaluated the neuroprotective effects of two well-known mood stabilizers, lithium and valproic acid (VPA), against colchicine neurotoxicity in cerebellar granule cells (CGNs). METHODS: The CGNs were differentiated for 7 days, pretreated with lithium or VPA for 24 h and after colchicine 1 microM was added. Cellular damage was assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) method and apoptosis in CGNs was characterized by chromatin condensation and DNA fragmentation. RESULTS: Incubation with lithium (1-5 mM) attenuated this apoptosis markedly, in a dose-dependent way however, the addition of VPA (0.5-2 mM) did not protect CGNs. Colchicine-induced apoptosis is mediated through the activation of caspase-3. An increase in caspase-3 activity was detected within 18 h and was blocked in presence of lithium 5 mM. CONCLUSIONS: Our data indicate that lithium treatment is selectively neuroprotective; however, in our experimental conditions VPA did not protect CGNs from apoptosis induced by colchicine. Our results support the hypothesis that distinct pathways mediate the neuroprotective effects of lithium and VPA.
Authors:
E G Jordà; E Verdaguer; A Morano; A Jiménez; A M Canudas; A Camins; M Pallàs
Related Documents :
22330343 - Assaying macrophage activity in a murine model of inflammatory bowel disease using fluo...
12934083 - Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is ...
19318573 - Tw-37, a small-molecule inhibitor of bcl-2, inhibits cell growth and induces apoptosis ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Bipolar disorders     Volume:  6     ISSN:  1398-5647     ISO Abbreviation:  Bipolar Disord     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-03-09     Completed Date:  2004-07-15     Revised Date:  2007-03-22    
Medline Journal Info:
Nlm Unique ID:  100883596     Medline TA:  Bipolar Disord     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  144-9     Citation Subset:  IM    
Affiliation:
Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Nucli Universitari de Pedralbes, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects*
Cerebellum / drug effects*,  pathology*
Colchicine / administration & dosage,  antagonists & inhibitors*,  pharmacology*
Colorimetry
Flow Cytometry
Gout Suppressants / administration & dosage,  pharmacology*
Lithium Carbonate / administration & dosage,  pharmacology*
Neurons / drug effects*,  pathology*
Neuroprotective Agents / administration & dosage,  pharmacology*
Rats
Rats, Sprague-Dawley
Chemical
Reg. No./Substance:
0/Gout Suppressants; 0/Neuroprotective Agents; 554-13-2/Lithium Carbonate; 64-86-8/Colchicine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Next Document:  von Willebrand's disease and psychotic disorders: co-segregation and genetic associations.